wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33764253-BE32AD5C-FD32-413F-A4E0-393F01C34185
Q33764253-BE32AD5C-FD32-413F-A4E0-393F01C34185
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33764253-BE32AD5C-FD32-413F-A4E0-393F01C34185
Selecting the best frontline treatment in chronic myeloid leukemia
P2860
Q33764253-BE32AD5C-FD32-413F-A4E0-393F01C34185
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33764253-BE32AD5C-FD32-413F-A4E0-393F01C34185
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
66ee1c130d0dff4f8b41ccd08b1632637d830bd5
P2860
Immune modulation of minimal residual disease in early chronic phase chronic myelogenous leukemia: a randomized trial of frontline high-dose imatinib mesylate with or without pegylated interferon alpha-2b and granulocyte-macrophage colony-stimulatin